This position is no longer accepting applications

French-speaking Senior OTC Analyst at Viatris (2) has been filled or removed.

Get notified about similar roles

We'll email you when new roles in Budapest, Budapest, Hungary are posted.

French-speaking Senior OTC Analyst

Viatris (2)·
Budapest, Budapest, Hungary
1w ago
Full-timeSeniorIT
Market Rate — Computer User Support Specialists
25th
$45K
Median
$58K
75th
$74K

BLS 2024 data (national)

Description

VIATRIS SERVICES KFT.<p style="text-align:inherit"></p><p style="text-align:inherit"></p><p style="text-align:left">At VIATRIS, we see healthcare not as it is but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.<br /><br />Viatris empowers people worldwide to live healthier at every stage of life.<br /><br />We do so via:<span>  </span><br /><br />Access – Providing high quality trusted medicines regardless of geography or circumstance;<br />Leadership – Advancing sustainable operations and innovative solutions to improve patient health; and<span>  </span><br />Partnership – Leveraging our collective expertise to connect people to products and services.<span>  </span><br /> </p><p>Do not post.</p><p style="text-align:inherit"></p><p style="text-align:left">A<span><span>t Viatris, we offer<span> </span></span></span><span><span>competitive<span> </span></span></span><span><span>salar</span></span><span><span>ies</span></span><span><span>, benefits</span></span><span><span><span> </span>and</span></span><span><span><span> </span></span></span><span><span>an inclusive environment where you can use your experiences, perspectives and skills to help make an impact on the lives of others.</span></span><span><span> </span></span></p><p style="text-align:inherit"></p><p style="text-align:left"><span>Viatris is an Equal Opportunity Employer. </span></p><p style="text-align:inherit"></p>
Viatris (2)

Viatris (2)

BIOTECHNOLOGY

Small Molecules, Generics

LocationChina - Shanghai
Open Jobs292
OncologyCardiovascularNeurologyInfectious DiseasesImmunology
View Company Profile